Cavalier Investments, LLC Corcept Therapeutics Inc Transaction History

Cavalier Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$12.27 - $15.65 $932,520 - $1.19 Million	-76,000 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$15.77 - $20.72 $804,270 - $1.06 Million	51,000 Added 204.0%	76,000 $1.37 Million
Q3 2017 Nov 02, 2017	BUY	$12.3 - $19.3 $307,500 - $482,500	25,000	25,000 $483,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.27B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.